Instil Bio Inc TIL

$5.84 +0.14 (2.46%)

Valuation

Market cap
39,607,000
Revenue TTM
$0
Net income TTM
$-71,370,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.79

Trading

Volume
121,300
Avg volume
24,286
Day's range
$5.66 – $5.90
Shares out
6,782,000
Stochastic %K
22%
Beta
1.94
Analysts
Hold
Price target
$7.00

Price

Company profile

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Industry
Biotechnology
Sector
Healthcare
Phone
972 499 3350
Website
https://instilbio.com
Address
3963 Maple Avenue, Suite 350, Dallas, United States

Latest news

Stocktwits

Magic8BallResponse Oct 13, 2:39 PM
$TIL Rally time.....
0 replies
Magic8BallResponse Oct 7, 7:51 PM
$TIL PRIME THE PUMP
0 replies
NVDAMillionaire Sep 24, 10:02 PM
$TIL Great piece that accurately captures TIL's current position. So if you want to refresh your understanding of TIL or learn about TIL for the first time, this is essential reading. https://everyticker.com/quote/TIL/analysis/instil-bio-s-phoenix-gambit-can-a-cash-strapped-biotech-rise-from-the-ashes-of-its-failed-til-program-nasdaq-til
0 replies
Magic8BallResponse Sep 21, 9:15 PM
$TIL Volume up
0 replies
filizius Aug 26, 2:31 PM 0 replies
Magic8BallResponse Jul 20, 7:29 PM
$TIL Time for a catalyst. Volume up
0 replies
BillionerOfKing Jul 9, 3:53 AM
$TIL Current Stock Price: $7.79
0 replies
MTRADe_01 Jun 26, 5:37 AM
$TIL Feels under the radar. • 56% insider ownership • ~36M float • Very little dilution • U.S. Army critical minerals/graphite catalyst • Improving production Not a squeeze play—more of a long-term re-rating candidate if management executes. Watching August earnings closely.
0 replies